Published in Endokrynol Pol on February 12, 1979
Clinical symptoms of mitral valve prolapse are related to hypomagnesemia and attenuated by magnesium supplementation. Am J Cardiol (1997) 1.78
1,161 patients with adrenal incidentalomas: indications for surgery. Langenbecks Arch Surg (2007) 1.34
Incidentally discovered adrenal mass (incidentaloma): investigation and management of 208 patients. Clin Endocrinol (Oxf) (1997) 1.24
Incidentally discovered adrenal tumors: a lesson from observation of 1,444 patients. Horm Metab Res (2008) 1.10
Low-molecular-weight heparins: pharmacologic profile and product differentiation. Am J Cardiol (1998) 0.99
Molecular profiling and weight determination of heparins and depolymerized heparins. J Pharm Sci (1995) 0.89
Affinity purification of heparin-dependent antibodies to platelet factor 4 developed in heparin-induced thrombocytopenia: biological characteristics and effects on platelet activation. Br J Haematol (2000) 0.87
[Antibodies directed against adrenal glands in Addison's and Cushing's diseases]. Pol Arch Med Wewn (1971) 0.86
Leptin and ghrelin concentrations and weight loss in Parkinson's disease. Acta Neurol Scand (2009) 0.85
Downregulation of clusterin expression in testicular germ cell tumours. Pathobiology (2001) 0.85
Structural features and anticoagulant activities of a novel natural low molecular weight heparin from the shrimp Penaeus brasiliensis. Biochim Biophys Acta (1999) 0.85
Ectopic ACTH syndrome due to bilateral ovarian androblastoma with double, gynandroblastic differentiation in one ovary. Eur J Obstet Gynecol Reprod Biol (1993) 0.84
Low molecular weight heparins: are they different? Can J Cardiol (1998) 0.83
The effect of metoclopramide, TRH and L-dopa on prolactin secretion in pituitary adenoma and in "functional" galactorrhoea syndrome. Acta Endocrinol (Copenh) (1979) 0.82
In vitro studies on the effect of activated protein C on platelet activation and thrombin generation. Thromb Res (1997) 0.82
Nelson's syndrome -- 46 years later: clinical experience with 37 patients. Zentralbl Neurochir (2006) 0.81
Effect of clonidine on beta-endorphin, ACTH and cortisol secretion in essential hypertension and obesity. Eur J Clin Pharmacol (1988) 0.81
[Clinical significance of anti-tbyroid antibodies in Addison's disease]. Pol Tyg Lek (1978) 0.81
[Radioimmunoassay of total serum thyroxine and triiodothyronine]. Endokrynol Pol (1977) 0.81
Comparative tissue factor pathway inhibitor release potential of heparins. Clin Appl Thromb Hemost (2005) 0.80
TFPI antigen levels in normal human volunteers after intravenous and subcutaneous administration of unfractionated heparin and a low molecular weight heparin. Thromb Res (1995) 0.80
Transdermal 17 beta-estradiol combined with oral progestogen increases plasma levels of insulin-like growth factor-I in postmenopausal women. J Endocrinol Invest (1992) 0.80
Nelson's syndrome: incidence and prognosis. Clin Endocrinol (Oxf) (1983) 0.79
Does leptin modulate immune and endocrine response in the time of LPS-induced acute inflammation? Neuro Endocrinol Lett (2001) 0.79
The role of tissue factor pathway inhibitor in the mediation of the antithrombotic actions of heparin and low-molecular-weight heparin. Blood Coagul Fibrinolysis (1995) 0.79
Comparative pharmacologic profile of a glycosaminoglycan mixture, Sulodexide, and a chemically modified heparin derivative, Suleparoide. Semin Thromb Hemost (1993) 0.79
Chylothorax in infancy. Thorax (1968) 0.79
Antithrombotic agents stimulate the synthesis and modify the sulfation pattern of a heparan sulfate proteoglycan from endothelial cells. Thromb Res (1994) 0.79
Serum prolactin responses to metoclopramide in Cushing's syndrome and Nelson's syndrome. Acta Endocrinol (Copenh) (1980) 0.79
Hyperinsulinaemia and decreased plasma levels of dehydroepiandrosterone sulfate in premenopausal women with coronary heart disease. J Intern Med (1995) 0.78
[Obstructive sleep apnea and risk factors for coronary artery disease]. Pneumonol Alergol Pol (2000) 0.78
The role of sex hormones in the mechanism of inhibited LH release in female patients with anorexia nervosa. Acta Endocrinol (Copenh) (1982) 0.78
Plasma immunoreactive atrial natriuretic factor is inhibited by selective blockade of alpha 2-adrenergic receptors in conscious Sprague-Dawley rats. Neurosci Lett (1987) 0.78
Are the available low-molecular-weight heparin preparations the same? Semin Thromb Hemost (1996) 0.77
Enhanced testosterone in female patients with anorexia nervosa: its normalization after weight gain. Acta Endocrinol (Copenh) (1979) 0.77
Plasma immunoreactive atrial natriuretic factor (IR-ANF) increases markedly after alpha 2-adrenergic stimulation with clonidine in normally-hydrated rats. Biochem Biophys Res Commun (1987) 0.77
Correlation between 21 amino acid endothelin, intrafollicular steroids and follicle size in stimulated cycles. Hum Reprod (1999) 0.77
Kinetic properties of human muscle pyruvate kinase. Mol Cell Biochem (1982) 0.77
Comment of long-acting lanreotide inducing clinical and biochemical remission of acromegaly caused by disseminated GHRH secreting carcinoid. J Clin Endocrinol Metab (1999) 0.77
Preclinical studies on a low molecular weight heparin. Thromb Res (1996) 0.77
Physical and pharmacologic manipulation of the vascular system as measured by the release of TFPI and other mediators of antithrombotic actions. Int Angiol (1996) 0.77
Anticoagulant and antithrombotic actions of a semisynthetic beta-1,3-glucan sulfate. Thromb Res (1995) 0.77
Serum prolactin in women with premenstrual syndrome. Mater Med Pol (1982) 0.77
Molecular profiling of heparinase-I resistant glycosaminoglycans in contaminated heparins. Comparative studies with uncontaminated heparin and porcine oversulfated chondroitin sulfate. Int Angiol (2008) 0.76
Low molecular weight heparins: a developmental perspective. Expert Opin Investig Drugs (1997) 0.76
The role of endogenous opiates in the mechanism of inhibited luteinizing hormone (LH) secretion in women with anorexia nervosa: the effect of naloxone on LH, follicle-stimulating hormone, prolactin, and beta-endorphin secretion. J Clin Endocrinol Metab (1984) 0.76
[Serum concentration of triiodothyronine, thyroxine and thyrotropin in elderly]. Endokrynol Pol (1977) 0.76
Ultrastructural changes in the central and peripheral nervous system in the rat with experimental allergic encephalomyelitis. Folia Neuropathol (1998) 0.76
The effect of some dithiocarbamic acids on dopamine-beta-hydroxylase and catecholamines level in rat's brain. Pol J Pharmacol Pharm (1976) 0.76
Radioimmunological determination of exogenous corticotropin-releasing hormone (CRH) and growth hormone-releasing hormone (GHRH): plasma half-life of CRH and GHRH. Endokrynol Pol (1989) 0.76
Exaggerated growth hormone response to growth hormone-releasing hormone in type I diabetes mellitus. Acta Endocrinol (Copenh) (1988) 0.76
Inhibitory effects of TFPI on thrombin and factor Xa generation in vitro--modulatory action of glycosaminoglycans. Thromb Res (1994) 0.76
Stress-induced injury of pig myocardium is accompanied by increased lipid peroxidation and depletion of mitochondrial ATP. Exp Pathol (1991) 0.76
The effect of naloxone on ATCH and beta-endorphin in patients with Cushing's disease. Acta Endocrinol (Copenh) (1985) 0.76
Incidentally found adrenal tumours: results of investigation of the pituitary-adrenal axis. Endokrynol Pol (1992) 0.75
Management of Nelson's syndrome: observations in fifteen patients. Clin Endocrinol (Oxf) (2001) 0.75
Cushing's syndrome in a 16-year-old girl due to ectopic ACTH precursor production from a pancreatic tumour. Clin Endocrinol (Oxf) (2001) 0.75
Cushing's syndrome secondary to ectopic ACTH secretion from a primary ovarian carcinoma. Clin Endocrinol (Oxf) (1997) 0.75
The effect of oral ethanol ingestion on the diurnal neurotensin secretion in man. Endokrynol Pol (1992) 0.75
Inactivation of factor Xa by the synthetic inhibitor DX-9065a causes strong anticoagulant and antiplatelet actions in human blood. Blood Coagul Fibrinolysis (1999) 0.75
Effects of cyproheptadine and metyrapone on ACTH and aldosterone concentrations in patients with Cushing's disease: a preliminary report. Mater Med Pol (1982) 0.75
The effect of naloxone on the secretion of pituitary hormones in patients with acromegaly, microprolactinomas, Cushing's disease and Nelson's syndrome. Endokrynol Pol (1986) 0.75
[Participation of polymorphonuclear leukocytes in basic defensive mechanisms]. Pediatr Pol (1981) 0.75
[Diagnostic value of the L-dopa test]. Endokrynol Pol (1976) 0.75
A modified method of aldosterone determination in plasma. Mater Med Pol (1977) 0.75
[Diagnostic significance of androgens separated by means of thin-layer chromatography]. Pol Tyg Lek (1973) 0.75
[Ultrasonography in the diagnosis of polycystic ovary syndrome]. Ginekol Pol (1982) 0.75
[Androgen fractionation obtained by means of thin-layer chromatography in cases of adrenocortical diseases]. Pol Tyg Lek (1973) 0.75
[Serum protein fractions of bone marrow in healthy humans]. Pediatr Pol (1969) 0.75
[Study of the interdependence between prostatic hypertrophy and disorders in hormone levels. Preliminary report. 1. Study of blood testosterone]. J Urol Nephrol (Paris) (1977) 0.75
[Hormonal changes in prostatic hypertrophy and cancer]. Endokrynol Pol (1982) 0.75
[Increased reverse triiodothyronine concentration in anorexia nervosa]. Endokrynol Pol (1981) 0.75
[Serum levels and urine excretion of corticoids in patients with prostatic hypertrophy]. Endokrynol Pol (1977) 0.75
The role of opioid peptides in the control of secretion of pituitary hormones. Mater Med Pol (1988) 0.75
[Hormonal disturbances in men with a prostatic adenoma (author's transl)]. J Urol (Paris) (1980) 0.75
The action of proteolytic enzymes on human muscle pyruvate kinase. Bull Acad Pol Sci Biol (1979) 0.75
Detection of endogenous LH-like and FSH-like activities in human prostate. Endokrynol Pol (1987) 0.75
The application of the modified method of determination of aldosterone in plasma. Mater Med Pol (1977) 0.75
[Serum protein fractions of bone marrow and peripheral blood in leukemia in children]. Pediatr Pol (1969) 0.75
Opposite effects of neuropeptide Y (NPY) and polypeptide YY (PYY) on plasma immunoreactive atrial natriuretic factor (IR-ANF) in rats. Biochem Biophys Res Commun (1987) 0.75
[Bronchogenic carcinoma associated with endocrine disorders]. Pol Tyg Lek (1972) 0.75
[The influence of spironolactone on the concentration of gonadotrophins and gonadal hormones in prostatic hypertrophy (author's transl)]. J Urol (Paris) (1981) 0.75
[Value of isotope renography using 131-I-hippurate]. Pol Tyg Lek (1972) 0.75
An enhanced diuresis and natriuresis in response to clonidine in spontaneously hypertensive rats. Endokrynol Pol (1989) 0.75
[Different hypogonadism mechanism in men and women suffering from Cushing's disease]. Endokrynol Pol (1981) 0.75
[Serum testosterone level and excretion of androgen metabolites in patients with hypertrophy of the prostatic gland]. Endokrynol Pol (1977) 0.75
[Role of hormonal disorders in the etiology of polycystic ovary syndrome (Stein-Leventhal syndrome)]. Endokrynol Pol (1982) 0.75
[Absorption of carbon disulfide by the skin from oil solutions]. Acta Pol Pharm (1966) 0.75
Clinical application of chromatographic separation of 17-ketosteroids. Mater Med Pol (1977) 0.75
Conversion of 3H-testosterone to dihydrotestosterone in human hypertrophic prostatic tissue. Nuklearmedizin (1979) 0.75
[Effect of dipyridamole on liver changes during acute poisoning with carbon tetrachloride in rats]. Pol Arch Med Wewn (1979) 0.75
[Evaluation of various neutrophil functions in infants with bacterial infections]. Pediatr Pol (1981) 0.75
[Role of hormonal factors in the pathogenesis of prostatic hypertrophy]. Pol Tyg Lek (1977) 0.75
The role of computed tomography in the localization of adrenal cortex tumors. Nuklearmedizin (1982) 0.75
[Case of Conn syndrome caused by adenoma of the adrenal cortex located by computed tomography]. Endokrynol Pol (1982) 0.75